Dyne Therapeutics maintains a strong $1.1B cash position, funding operations into mid-2028 despite heavy R&D and operating ...

Vitamin D deficiency, rampant in India at 70–90% of the population, adds another layer of trouble by curbing calcium absorption despite solid intake.